Exor Investments (UK) LLP
13F Reported Value
ⓘ$4.7B
incl. option notional
Equity Holdings
ⓘ$4.6B
Option Notional
ⓘ$19.1M
$0 puts / $19.1M calls
Holdings
32
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Exor Investments (UK) LLP disclosed 32 positions worth $4.7B in its Form 13F-HR for Q2 2026 — $4.6B in common stock plus $19.1M of put/call option positions (reported at underlying notional value, not premium at risk), led by $TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD) at 14.7% of the equity portfolio, followed by $CVNA and $MOH. During the quarter the fund opened 5 new positions and exited 9 — including a new stake in $MOH. The portfolio is most concentrated in Healthcare (28.9% of disclosed assets). All figures are sourced directly from Exor Investments (UK) LLP’s Form 13F-HR filing with the SEC under CIK 1732768.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- $684.6M20,205,943 sh
- 71.6#176
Quality
$611.1M9,283,819 sh - 56.5#1,154
Quality
$574.4M2,511,490 sh - 44.5
Quality
$455.8M46,061,363 sh - 79.4
Quality
$410.8M11,045,066 sh - —
Quality
$274.9M5,265,123 sh - 57.9
Quality
$205.7M4,391,097 sh - —
Quality
$188.2M31,531,500 sh - —
Quality
$175.1M2,411,493 sh - —
Quality
$162.0M19,075,936 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| — | $684.6M | 20,205,943 | |
| 71.6#176 | $611.1M | 9,283,819 | |
| 56.5#1,154 | $574.4M | 2,511,490 | |
| 44.5 | $455.8M | 46,061,363 | |
| 79.4 | $410.8M | 11,045,066 | |
| — | $274.9M | 5,265,123 | |
| 57.9 | $205.7M | 4,391,097 | |
| — | $188.2M | 31,531,500 | |
| — | $175.1M | 2,411,493 | |
| — | $162.0M | 19,075,936 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Exor Investments (UK) LLP's 32 positions.
Showing top 10 of 32 holdings.
Sector Allocation
Healthcare
$1.3B
Energy
$791.6M
Communication Services
$730.7M
Consumer Discretionary
$651.9M
Technology
$577.0M
Materials
$480.9M
Industrials
$55.6M
Utilities
$14.7M
Full Holdings — Exor Investments (UK) LLP (Q2 2026)
All 32 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $684.6M | 14.7% | -27% | — | |
| 2 | CARVANA CO. | $611.1M | 13.2% | +264% | 71.6 | |
| 3 | MOLINA HEALTHCARE, INC. | $574.4M | 12.4% | NEW | 56.5 | |
| 4 | Paramount Skydance Corp | $455.8M | 9.8% | +0% | 44.5 | |
| 5 | RANGE RESOURCES CORP | $410.8M | 8.8% | +54% | 79.4 | |
| 6 | VEON Ltd. | $274.9M | 5.9% | -13% | — | |
| 7 | SLB LIMITED/NV | $205.7M | 4.4% | -19% | 57.9 | |
| 8 | NOVAGOLD RESOURCES INC | $188.2M | 4.0% | -14% | — | |
| 9 | Valaris Ltd | $175.1M | 3.8% | -35% | — | |
| 10 | Sibanye Stillwater Ltd | $162.0M | 3.5% | -3% | — | |
| 11 | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $147.4M | 3.2% | +11% | — | |
| 12 | NVIDIA CORP | $133.6M | 2.9% | +9% | 85.9 | |
| 13 | FIRST MAJESTIC SILVER CORP | $90.5M | 1.9% | -47% | — | |
| 14 | Tempus AI, Inc. | $82.0M | 1.8% | +0% | 41.2 | |
| 15 | Cloudflare, Inc. | $73.6M | 1.6% | +0% | 56.4 | |
| 16 | Aurora Innovation, Inc. | $66.3M | 1.4% | +0% | 11.8 | |
| 17 | Nebius Group N.V. | $56.8M | 1.2% | +59% | — | |
| 18 | Moderna, Inc. | $53.5M | 1.1% | +0% | 21.2 | |
| 19 | MERCADOLIBRE INC | $40.8M | 0.9% | +0% | 80.2 | |
| 20 | Tesla, Inc. | $29.5M | 0.6% | +0% | 53.9 | |
| 21 | Sunshine Silver Mining & Refining Co | $26.4M | 0.6% | NEW | — | |
| 22 | Joby Aviation, Inc. | $21.5M | 0.5% | -36% | 29 | |
| 23 | INTUITIVE SURGICAL INC | $19.8M | 0.4% | -62% | 79.9 | |
| 24 | SLB LIMITED/NV | $19.1M | — | +0% | 57.9 | |
| 25 | Fervo Energy Co | $14.7M | 0.3% | NEW | — | |
| 26 | Pony AI Inc. | $12.6M | 0.3% | -45% | — | |
| 27 | NOVAGOLD RESOURCES INC | $11.3M | 0.2% | NEW | — | |
| 28 | RECURSION PHARMACEUTICALS, INC. | $8.1M | 0.2% | -62% | 23.3 | |
| 29 | ENVIRI Corp | $4.7M | 0.1% | NEW | 22.3 | |
| 30 | Duolingo, Inc. | $4.6M | 0.1% | +0% | 74.5 | |
| 31 | Klarna Group plc | $3.8M | 0.1% | NEW | — | |
| 32 | HARMONY GOLD MINING CO LTD | $2.5M | 0.1% | +0% | — |
New Positions (5)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Exor Investments (UK) LLP including:
Track Exor Investments (UK) LLP's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Exor Investments (UK) LLP and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Exor Investments (UK) LLP
13F Pro is an AI hedge fund tracker and stock research platform. For Exor Investments (UK) LLP (SEC CIK: 1732768), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Exor Investments (UK) LLP's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.